Ethical analysis to improve decision-making on health technologies

Samuli I Saarni; Bjørn Hofmann; Kristian Lampe; Dagmar Lühmann; Marjukka Mäkelä; Marcial Velasco-Garrido; Ilona Autti-Rämö

Ethical analysis to improve decision-making on health technologies

Samuli I Saarni, Bjørn Hofmann, Kristian Lampe, Dagmar Lühmann, Marjukka Mäkelä, Marcial Velasco-Garrido, Ilona Autti-Rämö

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

82 Citationer (Scopus)

Abstract

Udgivelsesdato: 2008-Aug

Originalsprog	Engelsk
Tidsskrift	Bulletin of the World Health Organization
Vol/bind	86
Udgave nummer	8
Sider (fra-til)	617-23
Antal sider	6
ISSN	0042-9686
Status	Udgivet - 2008

Bibliografisk note

Keywords: Attitude to Health; Cost-Benefit Analysis; Culture; Decision Making, Organizational; Diffusion of Innovation; Ethical Analysis; Health Policy; Humans; Interdisciplinary Communication; Internationality; Models, Organizational; Morals; Pilot Projects; Program Evaluation; Social Responsibility; Social Values; Technology Assessment, Biomedical

Citationsformater

@article{a3e06090bd2a11dd8e02000ea68e967b,

title = "Ethical analysis to improve decision-making on health technologies",

abstract = "Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.",

author = "Saarni, {Samuli I} and Bj{\o}rn Hofmann and Kristian Lampe and Dagmar L{\"u}hmann and Marjukka M{\"a}kel{\"a} and Marcial Velasco-Garrido and Ilona Autti-R{\"a}m{\"o}",

note = "Keywords: Attitude to Health; Cost-Benefit Analysis; Culture; Decision Making, Organizational; Diffusion of Innovation; Ethical Analysis; Health Policy; Humans; Interdisciplinary Communication; Internationality; Models, Organizational; Morals; Pilot Projects; Program Evaluation; Social Responsibility; Social Values; Technology Assessment, Biomedical",

year = "2008",

language = "English",

volume = "86",

pages = "617--23",

journal = "Bulletin of the World Health Organization",

issn = "0042-9686",

publisher = "World Health Organization",

number = "8",

}

TY - JOUR

T1 - Ethical analysis to improve decision-making on health technologies

AU - Saarni, Samuli I

AU - Hofmann, Bjørn

AU - Lampe, Kristian

AU - Lühmann, Dagmar

AU - Mäkelä, Marjukka

AU - Velasco-Garrido, Marcial

AU - Autti-Rämö, Ilona

N1 - Keywords: Attitude to Health; Cost-Benefit Analysis; Culture; Decision Making, Organizational; Diffusion of Innovation; Ethical Analysis; Health Policy; Humans; Interdisciplinary Communication; Internationality; Models, Organizational; Morals; Pilot Projects; Program Evaluation; Social Responsibility; Social Values; Technology Assessment, Biomedical

PY - 2008

Y1 - 2008

N2 - Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.

AB - Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.

M3 - Journal article

C2 - 18797620

SN - 0042-9686

VL - 86

SP - 617

EP - 623

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

IS - 8

ER -